Miguel, Juliana, Luiz Henrique Araujo, and Rodrigo Costa. 2020. “Cost-Effectiveness of Erlotinib Compared to Gefitinib for NSCLC With EGFR Mutations at the Inca”. Jornal Brasileiro De Economia Da Saúde 12 (1):8-15. https://doi.org/10.21115/JBES.v12.n1.p8-15.